Tang, Y., Ou, Z., Yao, Z., & Qiao, G. (2019). A case report of immune checkpoint inhibitor nivolumab combined with anti-angiogenesis agent anlotinib for advanced esophageal squamous cell carcinoma. Medicine (Baltimore).
Chicago Stili AlıntıTang, Yong, Zhu’an Ou, Zhifang Yao, ve Guibin Qiao. "A Case Report of Immune Checkpoint Inhibitor Nivolumab Combined With Anti-angiogenesis Agent Anlotinib for Advanced Esophageal Squamous Cell Carcinoma." Medicine (Baltimore) 2019.
MLA AlıntıTang, Yong, Zhu’an Ou, Zhifang Yao, ve Guibin Qiao. "A Case Report of Immune Checkpoint Inhibitor Nivolumab Combined With Anti-angiogenesis Agent Anlotinib for Advanced Esophageal Squamous Cell Carcinoma." Medicine (Baltimore) 2019.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..